Oncobesity News Posts

MAHA idealism meets political reality as RFK Jr. attempts to wrangle a growing movement
Health and Human Services Secretary Robert F. Kennedy, Jr., arrives on stage at the inaugural Make America Healthy Again summit at the Waldorf Astoria, Wednesday,

Once-a-day pill could offer a cheaper alternative to weight loss jabs
About 2.5million people in the UK use GLP-1 drugs for weight loss

Making GLP-1 weight loss drugs cheaper isn’t enough to address America’s obesity problem – here’s why
Polling shows that 1 in 8 Americans have tried GLP-1 drugs. zimmytws/iStock via Getty Images Plus The Trump administration is making a significant effort to

Why ‘starving cancer’ could be key to slowing disease growth, according to doctors
What we eat plays a major role in our health and well-being, especially in the development of chronic disease. On a recent episode of Dr.

Brain scientists are seeking weight-loss drugs without the nausea : Shots – Health News – NPR
Brain scientists are seeking weight-loss drugs without the nausea : Shots – Health News NPR Brain activity associated with breakthrough food preoccupation in an individual on

Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
:,这一成果由礼来公司Irina Jouravskaya研究小组经过不懈努力而取得。2025年11月20日出版的《柳叶刀》发表了这项成果。背景:肥胖是一种慢性疾病,是2型糖尿病及其并发症的重要诱因。…

Opinion: Trump’s regressive deal on GLP-1s misses the mark for patients like me
The U.S. government is finally flexing its negotiating muscle to reduce GLP-1 prices and expand access to these medicines — for weight loss — in

I lost 30kg on Ozempic and Wegovy. Everyone says the jabs are ageing but I look 10 years YOUNGER. Here’s how I did it
While headlines about ‘Ozempic face’ warn that the rapid weight loss associated with GLP-1 drugs can prematurely age people’s skin, Andrea says she’s experienced the

GLP-1s could end up being ‘the first true longevity drug’ as the world battles a rising obesity crisis
GLP-1s are the hottest drugs on the market. While doctors have prescribed these drugs to treat type-2 diabetes for decades, these treatments broke into the

Oral GLP-1 pill shows strong weight loss and blood sugar benefits in adults with diabetes
A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to

Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes
OBJECTIVE Patients with type 2 diabetes (T2D) are at increased risk of acute pancreatitis (AP) and biliary events. Evidence remains mixed regarding the association between

Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes
OBJECTIVE To assess the effect of automated insulin delivery (AID) on glycemic and insulin outcomes in adults with insulin-treated type 2 diabetes using a glucagon-like

MAHA And GLP-1s Are About To Deal A Big Blow To The Processed-Foods Industrial Complex
MAHA And GLP-1s Are About To Deal A Big Blow To The Processed-Foods Industrial Complex The US processed-food industrial complex, partly controlled by globalist mega-corps, is beginning

Ozempic could redefine Thanksgiving across the country as users’ appetites dwindle: ‘I don’t want to hurt anyone’s feelings’
‘I will just grab the dish and not eat it,’ one GLP-1 medication user said of her favorite Thanksgiving dish

Pfizer (PFE) – Hedged Covered Call Income Campaign
Pfizer (PFE) – Hedged Covered Call Income Campaign Pfizer, Inc. BATS:PFE Wallstreet-Warriors After Pfizer’s return to price levels closer to its pre-COVID range, I personally

New clinical trial involving more than 1,600 people with type 2 diabetes has found that a GLP-1 pill form of the drug orforglipron is similarly effective for weight loss as injectable semaglutide such as Ozempic
submitted by /u/sciencealert [link] [comments]

Study compares GLP-1 drug benefits and finds substantial variation in clinical effects
GLP-1 receptor agonists improve glycaemic control and provide renal, metabolic, and selective cardiovascular benefits in people with type 2 diabetes, based on an umbrella review

Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Advancements in Genetically-targeted Therapies, along with Innovative Treatments such as GLP-1 Receptor Agonists | DelveInsight
The alcohol use disorder (AUD) market is set to grow due to unmet clinical needs, limited efficacy of current therapies, and rising demand for better-tolerated

Online scammers targeting animal lovers this holiday season
A few years ago, Santa Claus brought my daughter a puppy. Yep, on the morning of her 9th Christmas, Carina came downstairs and there he

Meghan Trainor Reveals Health Scare That Led to 60lb Weight Loss
Meghan Trainor is opening up about her weight loss journey. Earlier this year, 31-year-old “Made You Look” singer revealed she began taking the GLP-1 medication

VKTX Completes Enrollment in First Late-Stage Study on Obesity Drug
Viking Therapeutics VKTX announced that it has completed enrolling study participants in the phase III VANQUISH-1 study, which is evaluating the safety and efficacy of the

Meal Prep Tips for Staying on Track with GLP-1 Medications
If your GLP-1 medication has dialed down your appetite or made certain foods unappealing (4) (1), smart meal prep can keep you nourished and on

GLP-1 “structural disruption” to food, drinks – study
The rising use of GLP-1 weight-loss drugs is a “structural disruption” to the food and drinks sector and “not a fad”, new GlobalData research suggests.

Multiomic study shows antiaging effects of GLP-1RAs
Could GLP-1 receptor agonists (GLP-1RAs), already used in obesity and diabetes, be repurposed as drugs to slow aging? Hong Kong, one of the places in

Biocon in very unique position globally as a biosimilars leader: Kiran Mazumdar-Shaw
Biocon is entering a transformative phase, leveraging regulatory shifts in the US and a strong insulin and GLP-1 portfolio to accelerate growth in the biologics

Low Doses of Ozempic-Like Drug Can Counteract Aging in Older Mice, Study Finds
A new study published in the journal Cell Metabolism strongly suggests that low doses of weight loss drugs like Ozempic and Zepbound can counteract aging

An Oral GLP-1 Pill Could Change the Future of Diabetes Care
Post Content

Novo Nordisk Alzheimer’s studies may reveal GLP-1 benefits | REUTERS
Studies from Novo Nordisk will give the strongest indication yet of whether blockbuster GLP-1 drugs, a class being used by millions for diabetes and weight

The Free Market Alone Won’t Cut GLP-1 Prices
Absent tools such as rebate reform, transparent pricing or accelerated biosimilar substitution, true price competition will remain limited.

AI treatment for weight-loss: Artificial Intelligence tools help researchers analyze 1,300 medical conditions, right medicines
Researchers analyzed 14 million doctors’ notes and 15 million clinical data entries from more than 135,000 patients with and without diabetes who each took only

Q&A: Navigating weight loss—when to consider bariatric surgery after GLP-1 therapy
People who have used GLP-1 medications—better known by their brand names like Ozempic, Mounjaro or Wegovy—have likely seen meaningful changes in their health, such as

Daily pill could offer alternative to weight-loss injections
Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it seems less effective than

Study compares the kidney, cardiovascular and mortality risks of three different GLP-1 RAs
Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent years, with popular types like semaglutide (sold

Beyond GLP-1: Eli Lilly’s Expanding Drug Portfolio Lifts Sales
Eli Lilly and Company’s LLY stock crossed the $1000 per share mark for the first time on Nov. 12, reaching new highs. It is also

EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth?
Embecta Corp. EMBC is set to release fourth-quarter fiscal 2025 results on Nov. 25, before the market opens. Here’s a brief review of the company’s

High-Stakes Novo Nordisk Alzheimer’s Studies Could Yield Answers on GLP-1 Benefit
By Deena Beasley and Julie Steenhuysen(Reuters) -Studies from Novo Nordisk due early next month will give the strongest indication yet of whether…

‘Exciting’ daily pill helps people lose 10% of weight in 18 months, study finds
A daily pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth of their body

High-stakes Novo Nordisk Alzheimer’s studies could yield answers on GLP-1 benefit – Reuters
High-stakes Novo Nordisk Alzheimer’s studies could yield answers on GLP-1 benefit Reuters

A step forward for knee osteoarthritis pain . . . and other research
Liraglutide for minor acute ischaemic strokePeople with diabetes who have a minor acute ischaemic stroke are at high risk of having another stroke within three

Equinox has too many next big bets to count
It took the Equinox Group—the parent company of luxury gym chain Equinox, Equinox hotels, and Soulcycle—around five years to recover from COVID. But the company